These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
245 related items for PubMed ID: 8126083
1. Regulation of bone marrow stromal cell differentiation by cytokines whose receptors share the gp130 protein. Gimble JM, Wanker F, Wang CS, Bass H, Wu X, Kelly K, Yancopoulos GD, Hill MR. J Cell Biochem; 1994 Jan; 54(1):122-33. PubMed ID: 8126083 [Abstract] [Full Text] [Related]
2. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors. Malaval L, Liu F, Vernallis AB, Aubin JE. J Cell Physiol; 2005 Aug; 204(2):585-93. PubMed ID: 15751050 [Abstract] [Full Text] [Related]
3. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family. Montero-Julian FA, Brailly H, Sautès C, Joyeux I, Dorval T, Mosseri V, Yasukawa K, Wijdenes J, Adler A, Gorin I, Fridman WH, Tartour E. Clin Cancer Res; 1997 Aug; 3(8):1443-51. PubMed ID: 9815830 [Abstract] [Full Text] [Related]
4. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells. Bellido T, Stahl N, Farruggella TJ, Borba V, Yancopoulos GD, Manolagas SC. J Clin Invest; 1996 Jan 15; 97(2):431-7. PubMed ID: 8567964 [Abstract] [Full Text] [Related]
5. Interleukin-6-type cytokines stimulate mesenchymal progenitor differentiation toward the osteoblastic lineage. Taguchi Y, Yamamoto M, Yamate T, Lin SC, Mocharla H, DeTogni P, Nakayama N, Boyce BF, Abe E, Manolagas SC. Proc Assoc Am Physicians; 1998 Jan 15; 110(6):559-74. PubMed ID: 9824538 [Abstract] [Full Text] [Related]
6. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor. Nandurkar HH, Hilton DJ, Nathan P, Willson T, Nicola N, Begley CG. Oncogene; 1996 Feb 01; 12(3):585-93. PubMed ID: 8637716 [Abstract] [Full Text] [Related]
7. Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells. Gimble JM, Morgan C, Kelly K, Wu X, Dandapani V, Wang CS, Rosen V. J Cell Biochem; 1995 Jul 01; 58(3):393-402. PubMed ID: 7593260 [Abstract] [Full Text] [Related]
8. Soluble glycoprotein 130 (gp130) attenuates OSM- and LIF-induced cartilage proteoglycan catabolism. Hui W, Bell M, Carroll G. Cytokine; 2000 Feb 01; 12(2):151-5. PubMed ID: 10671300 [Abstract] [Full Text] [Related]
9. A ciliary neurotrophic factor-sensitive human myeloma cell line. Gu ZJ, Zhang XG, Hallet MM, Lu ZY, Wijdenes J, Rossi JF, Klein B. Exp Hematol; 1996 Aug 01; 24(10):1195-200. PubMed ID: 8765494 [Abstract] [Full Text] [Related]
10. Osteoblastic gene expression during adipogenesis in hematopoietic supporting murine bone marrow stromal cells. Dorheim MA, Sullivan M, Dandapani V, Wu X, Hudson J, Segarini PR, Rosen DM, Aulthouse AL, Gimble JM. J Cell Physiol; 1993 Feb 01; 154(2):317-28. PubMed ID: 8425912 [Abstract] [Full Text] [Related]
12. Reduced expression of interleukin-11 in bone marrow stromal cells of senescence-accelerated mice (SAMP6): relationship to osteopenia with enhanced adipogenesis. Kodama Y, Takeuchi Y, Suzawa M, Fukumoto S, Murayama H, Yamato H, Fujita T, Kurokawa T, Matsumoto T. J Bone Miner Res; 1998 Sep 01; 13(9):1370-7. PubMed ID: 9738508 [Abstract] [Full Text] [Related]
13. Adipogenesis in a murine bone marrow stromal cell line capable of supporting B lineage lymphocyte growth and proliferation: biochemical and molecular characterization. Gimble JM, Dorheim MA, Cheng Q, Medina K, Wang CS, Jones R, Koren E, Pietrangeli C, Kincade PW. Eur J Immunol; 1990 Feb 01; 20(2):379-87. PubMed ID: 2178944 [Abstract] [Full Text] [Related]
14. LIF, but not IL-6, regulates osteoprogenitor differentiation in rat calvaria cell cultures: modulation by dexamethasone. Malaval L, Gupta AK, Liu F, Delmas PD, Aubin JE. J Bone Miner Res; 1998 Feb 01; 13(2):175-84. PubMed ID: 9495510 [Abstract] [Full Text] [Related]
16. Are LIF and related cytokines functionally equivalent? Piquet-Pellorce C, Grey L, Mereau A, Heath JK. Exp Cell Res; 1994 Aug 01; 213(2):340-7. PubMed ID: 8050491 [Abstract] [Full Text] [Related]
17. Ligand/receptor signaling threshold (LIST) model accounts for gp130-mediated embryonic stem cell self-renewal responses to LIF and HIL-6. Viswanathan S, Benatar T, Rose-John S, Lauffenburger DA, Zandstra PW. Stem Cells; 2002 Aug 01; 20(2):119-38. PubMed ID: 11897869 [Abstract] [Full Text] [Related]
18. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene. Liu J, Spence MJ, Wallace PM, Forcier K, Hellström I, Vestal RE. Cell Growth Differ; 1997 Jun 01; 8(6):667-76. PubMed ID: 9186000 [Abstract] [Full Text] [Related]
19. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression. Westendorf JJ, Jelinek DF. J Immunol; 1996 Oct 01; 157(7):3081-8. PubMed ID: 8816418 [Abstract] [Full Text] [Related]
20. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130. Taga T, Narazaki M, Yasukawa K, Saito T, Miki D, Hamaguchi M, Davis S, Shoyab M, Yancopoulos GD, Kishimoto T. Proc Natl Acad Sci U S A; 1992 Nov 15; 89(22):10998-1001. PubMed ID: 1438305 [Abstract] [Full Text] [Related] Page: [Next] [New Search]